| DC Field | Value | Language |
|---|
| dc.contributor.author | Polonikov, A. | - |
| dc.contributor.author | Zvyagina, M. | - |
| dc.contributor.author | Krivoshei, I. | - |
| dc.contributor.author | Sirotina, S. | - |
| dc.contributor.author | Churnosov, M. | - |
| dc.date.accessioned | 2020-01-31T13:46:24Z | - |
| dc.date.available | 2020-01-31T13:46:24Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients / A. Polonikov [et al.] // Annals Academy of Medicine, Singapore. - 2015. - Vol.44, №10, suppl.1.-P. S319. - (Advancing Healthcare Into The Future: Innovate, Improve, Integrate : 6th Singapore Health and Biomedical Congress, Singapore, 2-3 October 2015). | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/28298 | - |
| dc.description.abstract | Polymorphic genes involved in the regulation of lipid metabolism may be responsible for interindividual differences in efficiency of hypolipidaemic therapy. In the present prospective and randomised study, we investigated the efficacy of rosuvastatin (10 mg/day) in lipid-lowering therapy in 62 patients with coronary artery disease (CAD) possessing different genotypes of lipoprotein lipase (LPL) gene | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | medical genetics | ru |
| dc.subject | genetic polymorphism | ru |
| dc.subject | coronary artery disease | ru |
| dc.subject | CAD | ru |
| dc.subject | lipid-lowering therapy | ru |
| dc.subject | pharmacology | ru |
| dc.subject | rosuvastatin | ru |
| dc.title | Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
